Anti-EIF3L antibodies are used in the immunodetection of the protein eukaryotic translation initiation factor 3 subunit L. In humans, the canonical protein has a reported length of 564 amino acid residues and a mass of 66.7 kDa. Its subcellular localization is in the cytoplasm. Up to 2 different isoforms have been reported for this protein. It is notably expressed in many tissues, such as the pancreas and placenta. A member of the EIF-3 subunit L protein family, EIF3L is a known component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. Synonyms for this target antigen include EIF3S11, EIF3S6IP, HSPC021, HSPC025, MSTP005, and EIF3EIP. EIF3L gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of EIF3L antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunofluorescence are also common applications.